Clinical Trial Update: Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

A Phase 2 efficacy and safety trial of Poly-gamma Glutamic Acid (PGA) for cervical intraepithelial neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Poly-gamma Glutamic Acid (poly-gamma-glutamic acid)

Snippet

Sponsor: BioLeaders Corporation | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED